Scarica l'app Stockscreener
4.71
9.94%
-0.52
Dopo l'orario di chiusura:
4.76
0.05
+1.06%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché PRTG Giù?
Forum
Previsione
Frazionamento azionario
Portage Biotech Inc Borsa (PRTG) Ultime notizie
What is the investor’s view on Portage Biotech Inc (PRTG)? - US Post News
Pre-Market Surge: Portage Biotech (PRTG) Sees Upward Movement - Stocks Telegraph
Portage Biotech Secures $2.15 Million in Private Financing - TipRanks
Portage Biotech Announces Completion of $2.15 Million Private Financing - The Manila Times
Portage Biotech, Inc. Completes $2.15 Million Private Placement to Support Corporate Growth - Nasdaq
Insider Confidence: Portage Directors Invest $2.15M in Strategic Private Placement - StockTitan
Portage Biotech (NASDAQ:PRTG) Stock Price Down 7.2% – Here’s What Happened - Defense World
Portage Biotech Inc. Appoints Peter Molloy as CEO of Subsidiary, Cyncado Therapeutics, Inc - Marketscreener.com
Portage Biotech Re-Launches Subsidiary as Cyncado Therapeutics with New CEO - TipRanks
Portage Biotech Announce Re-Launch of Adenosine Subsidiary as Independently Managed Company; Appointment of Peter Molloy to Lead New Company - The Manila Times
Portage Biotech Launches Cyncado Therapeutics to Pioneer Advanced Cancer Immunotherapy Development - StockTitan
(PRTG) Trading Signals - Stock Traders Daily
(PRTG) Trading Advice - Stock Traders Daily
Portage Biotech Inc (PRTG) Recovers 276.55% From Low: Are We There Yet? - Stocks Register
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Portage Biotech Stock More Than Doubles On Immunova Deal Potential: Retail Sees Big Opportunity - MSN
Portage Biotech Inc. Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd - Marketscreener.com
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket - Benzinga
Portage Biotech soars after initiating proceedings for iOx Therapeutics sale - Mugglehead
What's Going On With Portage Biotech Shares Tuesday?Portage Biotech (NASDAQ:PRTG) - Benzinga
Crude Oil Down Over 1%; US Industrial Production Declines In November - Benzinga
Portage Biotech (PRTG) Stock Soars Amid Strategic Transaction - Stocks Telegraph
Strategic moves ignite these stocks 🧨 - RagingBull
Portage Biotech Shares Double on Letter of Intent to Sell Subsidiary - MarketWatch
Dow Dips Over 200 Points; US Retail Sales Top Estimates - Benzinga
Clinical Trials News Live Feed - StockTitan
Cash-strapped Portage finds hope in sale of lead asset, subsidiary to Immunova - Fierce Biotech
Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd - The Manila Times
Portage Biotech Enters Negotiations with Immunova for iOx Acquisition - TipRanks
Portage Biotech enters LOI with Immunova for subsidiary sale - Investing.com
Portage Biotech Inc. Appoints New CEO Amid Leadership Change - TipRanks
Westport-based Portage Biotech faces delisting from Nasdaq - Hartford Business Journal
AI firm Xaira powers up C-suite with pharma vet—Chutes & Ladders - Fierce Biotech
Portage Biotech receives Nasdaq non-compliance notice By Investing.com - Investing.com Canada
Portage Biotech receives noncompliance notification from Nasdaq - TipRanks
Portage Biotech Receives Nasdaq Noncompliance Notice - TipRanks
Portage Biotech receives Nasdaq non-compliance notice - Investing.com
Portage Biotech Announces Receipt of Nasdaq Noncompliance Letter - The Manila Times
Full Stock Market News from 2024-12-06 - StockTitan
Portage Biotech Announces Key Leadership Changes - TipRanks
Portage Biotech (NASDAQ:PRTG) Stock Quotes, Forecast and News Summary - Benzinga
Portage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024 - The Manila Times
Portage Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 - Marketscreener.com
Portage Biotech Reports Reduced Losses and Strategic Plans - TipRanks
Portage Biotech Narrows Q3 Loss by 73% to $1.4M, Pauses Clinical Trial Amid Strategic Review - StockTitan
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 1.51% - MSN
Kronos mulls ‘strategic alternatives’ after axing cancer drug development - MSN
Insiders Who Purchased US$1.24m Of Portage Biotech Stock May Not Have Expected 11% Tumble - Simply Wall St
Portage Biotech's Market Cap Drops To US$4.3m Leaving Insiders With Losses - Yahoo Finance
ARMISTICE CAPITAL, LLC Reduces Stake in Portage Biotech Inc - GuruFocus.com
Portage Biotech Inc (PRTG) Quarterly 10-Q Report - Quartzy
RadNet, Inc. (RDNT): Strategic Collaboration with GE HealthCare Boosts Stock by 21% Amid Advancements in AI-Powered Imaging Solutions - BP Journal
Monte Rosa Therapeutics Soars on Novartis Deal: A Molecular Glue Revolution - BP Journal
Where are the Opportunities in (PRTG) - Stock Traders Daily
The abrdn share price has crashed 18% in a week, lifting the yield to a mind-blowing 10.35%! - Yahoo Finance UK
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.59% - MSN
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.25% - MSN
1.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):